BOP 2020 - Breast Oncology Program Retreat 2020
Feb 20 - Feb 20, 2020 | San FranciscoCAUS
LARVOL is not affiliated with Breast Oncology Program Retreat 2020 and all trademarks, logos, and brand names are property of their respective owners
Showing 6 abstracts linked to Trials
Breast cancer subtype specific association of pCR with MRI assessed tumor volume progression during NAC in the I-SPY 2 TRIAL
Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival
Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL
Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).
Using a breast cancer risk model and risk thresholds as a predictor of chemoprevention uptake
Personalized breast cancer screening in a population-based study: Women Informed to Screen Depending On Measures of Risk (WISDOM)